Le Lézard
Classified in: Health

Power Grids Constantly Under Assault, Franek Technologies Has The Solution


TUSTIN, Calif., Dec. 12, 2017 /PRNewswire/ -- With California wild fires raging once again and winter ice storms not far off, it seems like our power grids are constantly under assault. The outdoor elements coupled with old outdated laboratory facilities is far from the ideal environment for sensitive scientific equipment. Dirty power has significant effects on laboratory equipment instrumentation. Franek Technologies is very knowledgeable in understanding just how detrimental dirty laboratory power can be on scientific equipment and in turn how it can greatly impact your end results.

Franek Technologies was founded in 1974 and has built a strong reputation within the laboratory community with our Laboratory Protection Systems/Uninterruptible Power Supplies (LPS/UPS). Our products are reliable and our knowledge of power requirements as it relates to valuable scientific and research equipment is unparalleled. We pride ourselves in our ability to provide product-specific solutions for all your UPS needs. Free fast quotes start at www.franek.com or call 1-800-326-6480. (PRNewsfoto/Franek Technologies, Inc.)

Laboratory Power Protection is too important to be left to chance. Power companies work hard to avoid power outages, but even on sunny days power flickers, voltage surges, and static noise can degrade instrument performance and produce maintenance issues. Franek Technologies stands between you and your next power problem. A Franek Uninterruptible Power Supply Unit (UPS) will reduce downtime in the event of a brownout or blackout as the batteries will maintain power to your valuable equipment until backup power such as a generator can come online. The uninterruptible power supply protects against voltage float or sag, which can cause the current to increase thereby forcing your equipment to run at higher temperatures. If equipment is running at higher temperatures this will lead to component degradation and could lead to inaccurate or unreliable results. Poor power quality represents an enormous cost to the healthcare industry in reduced productivity, expensive retesting and re-calibration, lost reporting time and equipment damage. Field studies have shown that electronic equipment powered by a clean, continuous energy source has a longer life span and a lower overall cost of ownership.

Franek Technologies has the ability to provide product-specific solutions for your UPS needs. Franek is the leader in Certified Category III-3 Laboratory Protection Systems (UPS/LPS), the organization recommended by leading instrument manufacturers including Applied Biosystems/Life Technologies, Agilent, Illumina, Ion Torrent and Thermo-Fisher Scientific. Franek Technologies is constantly updating their database as manufactures continue to bring to market exciting, new, and innovative products. Franek Technologies is working to provide clean problem free power protection solutions for all clinical and scientific laboratories.

 

SOURCE Franek Technologies


These press releases may also interest you

at 07:45
Sensi.AI, a leader in AI-native, data, and analytics in senior care, today announced the appointment of in-home care leader Bob Roth to its Advisory Board. This partnership is an exciting validation of Sensi.AI's promise to enhance proactive,...

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...



News published on and distributed by: